SUMMARY Plasma DNA has been measured by a new physicochemical approach based on fluorimetric analysis of phenol extracted nucleic acids electrophoresed on polyacrylamide gels. This method is specific for native double-stranded DNA of molecular weight greater than 5 x 106. The use of plasma rigorously freed of leucocytes is essential to prevent falsely high values. When such precautions are taken levels seldom exceed 50 ng/ml in normal individuals. Plasma DNA was assayed in 107 samples from 47 patients with both active and inactive systemic lupus erythematosus. In direct contrast to several previous reports no significant increase of plasma DNA was found.
Circulating native, double-stranded deoxyribonucleic acid (dsDNA) has been reported in a wide variety of unrelated conditions such as systemic lupus erythematosus (SLE), rheumatoid arthritis, malignancy, liver disease, and in infective endocarditis, pulmonary embolism, and after surgery. '-7 In addition raised levels have also been reported after cardiac surgery involving periods of extracorporeal circulation,7 after haemodialysis,8 in patients on high-dose corticosteroid therapy,9 and in response to the injection of bacterial lipopolysaccharides.10
In some of the above conditions it is claimed that the levels of circulating DNA found are pathologically raised. However, there is a wide divergence of opinion as to what constitutes the normal level of circulating DNA, levels ranging from less than 50 ng/ml to as high as 13 * 8 Fg/ml having been reported.1 2 4-7 11-14 Confirmation of raised levels of circulating DNA in pathological states therefore requires resolution of this problem of the normal range. This wide variation in reported levels is probably partly due to lack of specificity in the assay method and also depends on whether the assay is performed on plasma or serum.
The relevance of circulating DNA has been a subject of much debate, particularly with regard to its possible role in immune complex formation in SLE. It has been suggested that the DNA in the majority of cases is of endogenous origin from tissue injury Accepted for publication 16 (traumatic or inflammatory) and therefore represents a nonspecific phenomenon.3 9 An alternative view is that in at least some cases the DNA may be of exogenous (for example, viral) origin. '5 16 Methods for the detection of circulating DNA include: (1) the diphenylamine reaction17; (2) immune precipitation by double diffusion in agarose18; (3) complement fixation2; (4) fluorimetry using ethidium bromide"; (5) counterimmunoelectrophoresis (CIE)7; (6) RNA-DNA hybridisation14; and (7) radioimmunoassay (RIA).'215 Many of these assays are indirect measurements of DNA and lack either specificity or sensitivity or both. Furthermore, nonspecific protein binding'2 or the presence of interfering substances such as serum chromogens has been found to cause falsely high values, as, for example, in the diphenylamine method. The RIA and modified CIE techniques are the most sensitive methods, the lower limit of detection being about 50 ng/ml of circulating dsDNA.
We have developed a physicochemical assay for circulating ds DNA which is specific, reproducible, and sensitive down to 50 ng/ml.
By this method a normal range for dsDNA was established and levels were studied with particular emphasis on SLE, covering a wide spectrum of presentations and monitored through periods of exacerbation and remission. Circulating DNA levels were also investigated after exposure to ultraviolet light, since sunlight is a known precipitating factor in SLE. Fig. 2 (lower) Fig. 2 (upper), gel 3) . In 11 subjects DNA levels were measured in both plasma and serum drawn at the same time. In the 5 subjects having detectable levels of DNA in plasma extracts the serum extracts showed a similar diffuse fluorescence to that described above for DNA added to serum. This diffuse fluorescence precluded accurate quantitation. Because of this marked difference between DNA levels in heparinised plasma and serum, DNA was assayed in plasma with both heparin and EDTA as anticoagulants and the levels compared with those in serum. The plasma levels were the same irrespective of whether heparin or EDTA was used. All subsequent determinations were therefore routinely performed on plasma.
The within-group variability of plasma DNA levels performed in duplicate on 42 samples showed a standard deviation of 13 8%. This degree of variability was maintained down to levels of about 40 ng/ml plasma. (Fig. 3) comprising 29 males and 29 females aged 15 to 68 years (mean 34 years). In 47 subjects (81 %) DNA levels were <10 ng/ml. In the remaining 11 subjects levels ranged from 10 to 54 ng/ml. There were no significant age or sex differences.
PHYSIOLOGICAL VARIATION IN DNA LEVELS
The effect on circulating DNA levels of exposure to the sunburn spectrum of ultraviolet light was tested in two normal Caucasian volunteers as follows: the minimal erythema dose (MED) was established for each subject, whereupon a whole-body exposure of 4 MED was administered to each subject by means of a Theraktin sunlamp fitted with a TL/1240 W fluorescent tube with a spectrum peaking at 306 nm.
Blood was drawn before and 6, 24, 48, and 72 hours after exposure and assayed for DNA. No DNA was detected in any of the samples.
Five blood samples were drawn from each of 4 male and female subjects aged 15-68 years (mean 37 years) over a 24-hour period and assayed for DNA. Plasma DNA levels remained undetectable (less than 10 ng/ml) in all subjects throughout the 24 hours. Association criteria for the classification of SLE,22 had 107 assays performed over a period of 8 months (Fig. 3) . None of these patients was on high-dose corticosteroid therapy at the time measurements were made. The majority had levels below 10 ng/ml, and in the few cases where higher levels were recorded no association could be established with respect to the type of organ involvement, nor were there significant differences in levels between clinically active and quiescent phases of the disease (Table 2) . Since high levels of circulating DNA have been reported after haemodialysis,8 plasma DNA levels were also measured in 4 patients with chronic renal failure (not associated with SLE) immediately on termination of 6 hours of haemodialysis. Two were found to have considerably elevated levels (Fig. 3) . The recovery studies have shown that dsDNA in plasma can be measured accurately at 50 ng/ml and above; below 50 ng/ml recovery falls appreciably.
Levels of plasma DNA found in normal subjects were considerably lower than those of some reported series,4 5 11 but similar to those reported by others.
16a713 It is most unlikely that this can be explained by differences in the selection of normal subjects and the reasons are presumably methodological. The importance of ensuring that plasma is completely free of white blood cells needs emphasis. Since 1 human leucocyte contains about 6 pg of DNA, it would require a contamination level of only 104 cells/ml plasma to give a DNA level of 60 ng/ml. It is therefore necessary to remove more than 99 9 % leucocytes from the plasma. This is especially relevant when an extraction procedure which disrupts membranes is used prior to assay.
In our small series of posthaemodialysis patients we found raised levels of plasma dsDNA as previously reported.8 However, in contrast to other reports' 2 4 5 raised plasma DNA levels were not observed in our patients with SLE, and in no instance was there any demonstrable relationship between plasma dsDNA levels and the type of organ involved. Neither did plasma dsDNA levels vary with disease activity. In some studies reporting raised DNA levels in SLE (e.g., Tan et al.1) patients were included who were receiving high-dose corticosteroid therapy, which is itself capable of increasing the level of DNA in blood.9 In other studies the predominant form of DNA measured was ssDNA,4 and these are not, therefore, strictly comparable with our findings. Unless increased entry of DNA into the circulation is a feature of SLE, it would in fact be logical to expect that the complexing of DNA with anti-DNA antibody would result in more rapid clearance of DNA from the circulation and therefore low circulating DNA levels. 
